Suppr超能文献

相似文献

3
CD69 marks a subpopulation of acute myeloid leukemia with enhanced colony forming capacity and a unique signaling activation state.
Leuk Lymphoma. 2023 Jul-Aug;64(7):1262-1274. doi: 10.1080/10428194.2023.2207698. Epub 2023 May 10.
4
HCK maintains the self-renewal of leukaemia stem cells via CDK6 in AML.
J Exp Clin Cancer Res. 2021 Jun 24;40(1):210. doi: 10.1186/s13046-021-02007-4.
6
CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
Cell Stem Cell. 2015 Oct 1;17(4):412-21. doi: 10.1016/j.stem.2015.08.008. Epub 2015 Sep 18.
7
Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
Cancer Res. 2019 Nov 15;79(22):5799-5811. doi: 10.1158/0008-5472.CAN-19-0274. Epub 2019 Sep 13.
10
IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.
Cell Stem Cell. 2019 Jan 3;24(1):153-165.e7. doi: 10.1016/j.stem.2018.10.016. Epub 2018 Nov 21.

引用本文的文献

2
Acquired resistance in cancer: towards targeted therapeutic strategies.
Nat Rev Cancer. 2025 Jun 3. doi: 10.1038/s41568-025-00824-9.
5
Aberrant stem cell and developmental programs in pediatric leukemia.
Front Cell Dev Biol. 2024 Mar 27;12:1372899. doi: 10.3389/fcell.2024.1372899. eCollection 2024.
6
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth.
Nat Commun. 2024 Feb 14;15(1):1359. doi: 10.1038/s41467-024-45691-4.
9
Identification of Cell Type-Specific Effects of Mutations on Relapse in Acute Myeloid Leukemia.
Mol Cells. 2023 Oct 31;46(10):611-626. doi: 10.14348/molcells.2023.0093. Epub 2023 Sep 27.
10
Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state.
Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2308658120. doi: 10.1073/pnas.2308658120. Epub 2023 Oct 16.

本文引用的文献

1
Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry.
JCI Insight. 2018 Dec 6;3(23):124928. doi: 10.1172/jci.insight.124928.
2
Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation.
Cell. 2018 May 31;173(6):1535-1548.e16. doi: 10.1016/j.cell.2018.03.074. Epub 2018 Apr 26.
3
Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR.
Leukemia. 2018 Jun;32(6):1445-1457. doi: 10.1038/s41375-018-0052-x. Epub 2018 Feb 27.
4
Peptidomimetic blockade of MYB in acute myeloid leukemia.
Nat Commun. 2018 Jan 9;9(1):110. doi: 10.1038/s41467-017-02618-6.
5
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
Leukemia. 2018 Apr;32(4):882-889. doi: 10.1038/leu.2017.317. Epub 2017 Nov 1.
6
Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways.
Sci Transl Med. 2017 Oct 25;9(413). doi: 10.1126/scitranslmed.aao1214.
7
Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML.
Blood. 2017 Dec 7;130(23):2469-2474. doi: 10.1182/blood-2017-08-784066. Epub 2017 Oct 19.
8
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia.
Cancer Res. 2017 Dec 1;77(23):6627-6640. doi: 10.1158/0008-5472.CAN-17-1223. Epub 2017 Sep 28.
9
Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia.
Leukemia. 2018 Apr;32(4):855-864. doi: 10.1038/leu.2017.300. Epub 2017 Sep 27.
10
S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.
Cancer Res. 2017 Oct 1;77(19):5360-5373. doi: 10.1158/0008-5472.CAN-17-1294. Epub 2017 Aug 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验